VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 145 participants.

Also called NCT04414878

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 145 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04414878
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04414878. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-31 (actual); primary completion 2022-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
Condition
Aortic Stenosis
Intervention (Device)
VitaFlow™ II Transcatheter Aortic Valve System
Lead sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04414878
Content hash
7b28be167d03e9b2b26117282512c4fcbc091c3c2b6177bc924eb53dce86b25f